Publication:
Efficacy of protracted dose-dense temozolomide (TMZ) in patients with progressive high-grade glioma

dc.contributor.authorsAbacioglu, M. U.; Caglar, H. B.; Yumuk, P. F.; Akgun, Z.; Atasoy, B. M.; Sengoz, M.
dc.date.accessioned2022-03-12T16:01:08Z
dc.date.accessioned2026-01-11T07:23:28Z
dc.date.available2022-03-12T16:01:08Z
dc.date.issued2009
dc.identifier.doidoiWOS:000276606602245
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224815
dc.identifier.wosWOS:000276606602245
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy of protracted dose-dense temozolomide (TMZ) in patients with progressive high-grade glioma
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume27

Files